Bonjesta

Active Ingredient(s): Doxylamine Succinate + Pyridoxine Hydrochloride
FDA Approved: * November 7, 2016
Pharm Company: * DUCHESNAY
Category: Nausea & Vomiting

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Bonjesta Overview

Doxylamine is a first-generation antihistamine. It can be used by itself as a short-term sedative and in combination with other drugs to provide night-time allergy and cold relief. Doxylamine is also used in combination with the analgesics paracetamol (acetaminophen) and codeine as an analgesic/calmative preparation, and is prescribed in combination with vitamin B6 (pyridoxine) to prevent morning sickness in pregnant women. Its fetal safety is "A" in Briggs’ Reference Guide to Foetal an...

Read more Bonjesta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Doxylamine

Recent Bonjesta Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Bonjesta: (1 result)

Sorted by National Drug Code

• 55494-120 Bonjesta Oral Tablet, Extended Release by Duchesnay USA, Inc.

Drugs with one or more similar ingredients: (3 results)

• DOXYLAMINE + PYRIDOXINE
• DICLEGIS Doxylamine Succinate + Pyridoxine Hydrochloride2 discussions
• MERSYNDOL Acetaminophen + Codeine Phosphate + Doxylamine Succinate5 discussions